A double-blind, double-dummy, randomised, placebo-controlled, four-way crossover study to investigate the effect of single oral doses of SB-649868 [GSK-649868] and of zolpidem in a model of noise induced situational insomnia in healthy male volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2017
At a glance
- Drugs GSK 649868; Zolpidem
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 18 Sep 2008 Actual patient number (52) added as reported by ClinicalTrials.gov.
- 17 Sep 2007 Status changed from recruited to completed.
- 04 Apr 2007 New trial record.